Sprint Bioscience AB's total assets for Q2 2025 were kr38.60M, an increase of 14.08% from the previous quarter. DE:5JA1 total liabilities were kr24.29M for the fiscal quarter, a -19.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.